Results 191 to 200 of about 37,704,421 (327)
Robust operation of renewable virtual power plant in intelligent distribution system considering active and reactive ancillary services markets. [PDF]
Vafa M, Ershadi MH, Arandian B.
europepmc +1 more source
Reference data set for a Norwegian medium voltage power distribution system. [PDF]
Sperstad IB +5 more
europepmc +1 more source
ONLINE NEWSPAPER DISTRIBUTION SYSTEM ONLINE NEWSPAPER DISTRIBUTION SYSTEM
Vijayalaxmi Kadroli, Vikas Khanase
semanticscholar +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Techno-economic analysis of distribution system at various load models using MEWOA algorithm. [PDF]
Zangmo R +5 more
europepmc +1 more source
Dataset for a Norwegian medium and low voltage power distribution system with industrial loads. [PDF]
Sandell S +3 more
europepmc +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Design and Characterization of a Self-Oscillating Fluxgate-Based Current Sensor for DC Distribution System Applications. [PDF]
Chen W, Chen H, Xu H, Li L.
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source

